SS&C Technologies Hldgs Bolsa (NASDAQ: SSNC)

Últimas noticias sobre SS&C Technologies Hldgs (NASDAQ:SSNC) Bolsa

SS&C TECHNOLOGIES HOLDINGS

SS&C Technologies Hldgs

SS&C Techs Hldgs

SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.

SS&C Technologies Holdings, Inc. - Common Stock

SS&C Technologies Holdings Inc

SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) has outperformed the market over the past 15 years by 9.91% on an annualized basis producing an average annual return of 21.89%. Currently, SS&amp;C Technologies Hldgs has a market capitalization of $19.80 billion. 
Buying $1000 In SSNC: If an investor had bought $1000 of SSNC stock 15 years ago, it would be worth $19,699.32 today based on a price of $79.93 for SSNC at the time of writing.
<h3>SS&amp;C Technologies Hldgs's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749078912_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

SSNC

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

Reported Earlier, Fundhost Selects SS&C To Support Fund Services Operations Including Unit Registry And Fund Administration

Reported Earlier, SS&C Renews Partnership With FES Super, Strengthening Position In Australian Superannuation Market

Buybacks

SS&C Technologies Expands Stock Repurchase Program To $1.5B, Up 50% From Last Year

SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) has outperformed the market over the past 15 years by 10.21% on an annualized basis producing an average annual return of 21.9%. Currently, SS&amp;C Technologies Hldgs has a market capitalization of $19.73 billion. 
Buying $100 In SSNC: If an investor had bought $100 of SSNC stock 15 years ago, it would be worth $1,921.83 today based on a price of $79.66 for SSNC at the time of writing.
<h3>SS&amp;C Technologies Hldgs's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747167316_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In SS&C Technologies Hldgs 15 Years Ago Would Be Worth This Much Today

SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) has outperformed the market over the past 15 years by 11.08% on an annualized basis producing an average annual return of 22.23%. Currently, SS&amp;C Technologies Hldgs has a market capitalization of $19.26 billion. 
Buying $1000 In SSNC: If an investor had bought $1000 of SSNC stock 15 years ago, it would be worth $19,733.33 today based on a price of $77.75 for SSNC at the time of writing.
<h3>SS&amp;C Technologies Hldgs's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746223213_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In SS&C Technologies Hldgs 15 Years Ago Would Be Worth Today

Reported Earlier, SS&C Secures Long-Term Agreement With REI Super To Support Australia's Real Estate Industry Fund

DA Davidson analyst Peter Heckmann maintains SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) with a Buy and lowers the price target from $100 to $94.

Price Target

Analyst Ratings

DA Davidson Maintains Buy on SS&C Technologies Hldgs, Lowers Price Target to $94

Raymond James analyst Patrick O'Shaughnessy maintains SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) with a Strong Buy and lowers the price target from $95 to $90.

Raymond James Maintains Strong Buy on SS&C Technologies Hldgs, Lowers Price Target to $90

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>BMO Capital raised O&#8217;Reilly Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) price target from $1,450 to $1,500. BMO Capital analyst Tristan Thomas-Martin maintained an Outperform rating. O&#8217;Reilly Automotive shares closed at $1,352.17 on Thursday. See how other analysts <a href="https://www.benzinga.com/quote/ORLY/analyst-ratings">view this stock</a>.</li>
<li>Barclays cut the price target for Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) from $86 to $84. Barclays analyst Benjamin Budish maintained an Overweight rating. Nasdaq shares closed at $74.74 on Thursday. <a href="https://www.benzinga.com/quote/NDAQ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham cut Plexus Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) price target from $172 to $162. Needham analyst James Ricchiuti reiterated a Buy rating. Plexus shares closed at $125.35 on Thursday. See how other analysts <a href="https://www.benzinga.com/quote/PLXS/analyst-ratings">view this stock</a>.</li>
<li>Barclays increased the price target for AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) from $27 to $30. Barclays analyst Kannan Venkateshwar maintained an Overweight rating. AT&amp;T shares closed at $27.53 on Thursday. <a href="https://www.benzinga.com/quote/T/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity raised the price target for Rollins, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROL#NYSE">ROL</a>) from $49 to $50. Canaccord Genuity analyst Brian McNamara maintained a Hold rating. Rollins shares closed at $55.47 on Thursday. <a href="https://www.benzinga.com/quote/ROL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo increased Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) price target from $167 to $175. Wells Fargo analyst Ken Gawrelski maintained an Equal-Weight rating. Alphabet shares settled at $159.28 on Thursday. <a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS increased Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) price target from $130 to $170. UBS analyst Faham Baig upgraded Philip Morris from Sell to Neutral. Philip Morris shares closed at $170.07 on Thursday. <a href="https://www.benzinga.com/quote/PM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham cut Euronet Worldwide, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEFT#NASDAQ">EEFT</a>) price target from $130 to $120. Needham analyst Mayank Tandon maintained a Buy rating. Euronet Worldwide shares closed at $98.94 on Thursday.  <a href="https://www.benzinga.com/quote/EEFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan cut the price target for SS&amp;C Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) from $90 to $86. JP Morgan analyst Alexei Gogolev downgraded the stock from Overweight to Neutral. SS&amp;C Technologies shares settled at $77.43 on Wednesday. <a href="https://www.benzinga.com/quote/SSNC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt slashed Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) price target from $18 to $14. Rosenblatt analyst Kevin Cassidy maintained a Sell rating. Intel shares closed at $21.49 on Thursday. <a href="https://www.benzinga.com/quote/INTC/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying T stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="597" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177-1024x597.png" alt="" class="wp-image-888747" style="width:602px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177-1024x597.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177-768x448.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25085047/image-177.png 1093w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45001899/alphabet-intel-and-3-stocks-to-watch-heading-into-friday">Alphabet, Intel And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

EEFT

GOOGL

INTC

NDAQ

ORLY

PLXS

AT&T To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Canaccord Genuity analyst Joseph Vafi downgraded the rating for ASGN Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) from Buy to Hold and lowered the price target from $115 to $55. ASGN shares closed at $51.76 on Thursday. <a href="https://www.benzinga.com/quote/ASGN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Alexei Gogolev downgraded SS&amp;C Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) from Overweight to Neutral and lowered the price target from $90 to $86. SS&amp;C Technologies shares closed at $77.43 on Thursday. <a href="https://www.benzinga.com/quote/SSNC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Macquarie analyst Linda Huang downgraded the rating for TAL Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) from Outperform to Neutral and cut the price target from $14.5 to $10.9. TAL Education shares closed at $8.93 on Thursday. <a href="https://www.benzinga.com/quote/TAL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Tiago Fauth downgraded United Therapeutics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NASDAQ">UTHR</a>) from Overweight to Equal-Weight and slashed the price target from $395 to $314. United Therapeutics shares closed at $296.42 on Thursday. <a href="https://www.benzinga.com/quote/UTHR/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying UTHR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="632" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25072624/image-173-1024x632.png" alt="" class="wp-image-888521" style="width:611px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25072624/image-173-1024x632.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25072624/image-173-300x185.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25072624/image-173-768x474.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25072624/image-173.png 1065w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45001899/alphabet-intel-and-3-stocks-to-watch-heading-into-friday">Alphabet, Intel And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Downgrades

ASGN

UTHR

This United Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

WIIM

SS&C Technologies shares are trading lower after the company issued Q2 guidance below estimates. Additionally, JP Morgan downgraded the stock from Overweight to Neutral and cut its price target from $90 to $98, while Needham lowered its price target from $105 to $90.

Needham analyst Mayank Tandon maintains SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) with a Buy and lowers the price target from $105 to $90.

Needham Maintains Buy on SS&C Technologies Hldgs, Lowers Price Target to $90

JP Morgan analyst Alexei Gogolev downgrades SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) from Overweight to Neutral and lowers the price target from $90 to $86.

JP Morgan Downgrades SS&C Technologies Hldgs to Neutral, Lowers Price Target to $86

SS&C Technologies shares are trading lower after the company issued Q2 adjusted EPS guidance below estimates.

SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) raises FY2025 Adj EPS guidance from $5.64-$5.96 to $5.68-$6.00 vs $5.85 analyst estimate. Narrows FY2025 sales outlook from $6.08 billion-$6.25 billion to $6.12 billion-$6.24 billion vs $6.19 billion estimate.

Guidance

SS&C Technologies Hldgs Raises FY2025 Adj EPS Guidance from $5.64-$5.96 to $5.68-$6.00 vs $5.85 Est; Narrows FY2025 Sales Guidance from $6.08B-$6.25B to $6.12B-$6.24B vs $6.19B Est

SS&amp;C Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) is looking for Q2 Adj EPS of $1.35-$1.41 vs $1.42 analyst estimate. sees sales of $1.489 billion-$1.529 billion vs $1.53 billion analyst estimate.

SS&C Technologies Hldgs Sees Q2 Adj EPS $1.35-$1.41 vs $1.42 Est; Sees Sales $1.489B-$1.529B vs $1.53B Est

SS&amp;C Techs Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) reported quarterly earnings of $1.44 per share which beat the analyst consensus estimate of $1.41 by 2.13 percent. This is a 12.5 percent increase over earnings of $1.28 per share from the same period last year. The company reported quarterly sales of $1.51 billion which beat the analyst consensus estimate of $1.50 billion by 0.69 percent. This is a 5.42 percent increase over sales of $1.44 billion the same period last year.

Earnings

Earnings Beats

SS&C Techs Hldgs Q1 Adj. EPS $1.44 Beats $1.41 Estimate, Sales $1.51B Beat $1.50B Estimate

ADXN

ALEX

ALLE

AMAL

AMBP

APOG

APPF

BAFN

BCPC

BELFA

BELFB

BFST

BHLB

BWMX

CBRE

CIVB

CMCSA

CNOB

COUR

CUBI

CURB

DAIO

DGICA

DGICB

ERIE

FARO

FBIZ

FCFS

FCNCA

FFBC

FRME

GBCI

GILD

GLPI

GNFT

GOOG

HELE

HFWA

IBCP

INDV

ITGR

KNSL

KRNY

LADR

LYTS

MBLY

MGRC

MMSI

MOFG

Earnings Scheduled For April 24, 2025

SS&amp;C Techs Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) will release its quarterly earnings report on Thursday, 2025-04-24. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate SS&amp;C Techs Hldgs to report an earnings per share (EPS) of $1.39.
SS&amp;C Techs Hldgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings History Snapshot</h3>
In the previous earnings release, the company beat EPS by $0.25, leading to a 6.0% increase in the share price the following trading session.
Here's a look at SS&amp;C Techs Hldgs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.33</td>
<td>1.26</td>
<td>1.20</td>
<td>1.21</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.58</td>
<td>1.29</td>
<td>1.27</td>
<td>1.28</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.0%</td>
<td>-7.000000000000001%</td>
<td>6.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745424159_0.png" alt="eps graph" />
<h3>Performance of SS&amp;C Techs Hldgs Shares</h3>
Shares of SS&amp;C Techs Hldgs were trading at $75.49 as of April 22. Over the last 52-week period, shares are up 25.03%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Views on SS&amp;C Techs Hldgs</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on SS&amp;C Techs Hldgs.
Analysts have given SS&amp;C Techs Hldgs a total of 9 ratings, with the consensus rating being Buy. The average one-year price target is $98.89, indicating a potential 31.0% upside.
<h3>Comparing Ratings with Competitors</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Broadridge Financial Soln, Genpact and ExlService Hldgs, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Broadridge Financial Soln, with an average 1-year price target of $247.5, suggesting a potential 227.86% upside.</li>
<li>Analysts currently favor an Buy trajectory for Genpact, with an average 1-year price target of $60.0, suggesting a potential 20.52% downside.</li>
<li>Analysts currently favor an Buy trajectory for ExlService Hldgs, with an average 1-year price target of $57.0, suggesting a potential 24.49% downside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
The peer analysis summary outlines pivotal metrics for Broadridge Financial Soln, Genpact and ExlService Hldgs, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>SS&amp;C Technologies Hldgs</td>
<td>Buy</td>
<td>8.37%</td>
<td>$753.90M</td>
<td>3.72%</td>
</tr>
<tr>
<td>Broadridge Financial Soln</td>
<td>Neutral</td>
<td>13.11%</td>
<td>$443.40M</td>
<td>6.42%</td>
</tr>
<tr>
<td>Genpact</td>
<td>Buy</td>
<td>8.94%</td>
<td>$445.77M</td>
<td>5.93%</td>
</tr>
<tr>
<td>ExlService Hldgs</td>
<td>Buy</td>
<td>16.27%</td>
<td>$183.40M</td>
<td>5.52%</td>
</tr>
</tbody>
</table>

Key Takeaway:
SS&amp;C Technologies Hldgs ranks at the top for Revenue Growth among its peers. It is in the middle for Gross Profit and at the bottom for Return on Equity.
<h3>Get to Know SS&amp;C Techs Hldgs Better</h3>
SS&amp;C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. SS&amp;C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&amp;C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&amp;C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&amp;C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&amp;C completed the acquisition of Blue Prism.
<h3>SS&amp;C Techs Hldgs: Delving into Financials</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Positive Revenue Trend: Examining SS&amp;C Techs Hldgs's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 8.37% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: SS&amp;C Techs Hldgs's net margin is impressive, surpassing industry averages. With a net margin of 16.23%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): SS&amp;C Techs Hldgs's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.72%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): SS&amp;C Techs Hldgs's ROA excels beyond industry benchmarks, reaching 1.32%. This signifies efficient management of assets and strong financial health.
Debt Management: SS&amp;C Techs Hldgs's debt-to-equity ratio is below the industry average at 1.1, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/SSNC/earnings">To track all earnings releases for SS&amp;C Techs Hldgs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For SS&C Techs Hldgs

Press Releases

REI Super Selects SS&C For Superannuation Administration

SS&C GlobeOp Hedge Fund Performance Index and Capital Movement Index

Alerian MLP ETF Declares Second Quarter Distribution of $0.98

Alerian Energy Infrastructure ETF Declares Second Quarter Distribution of $0.37707

SS&C GlobeOp Forward Redemption Indicator

SS&C Grows Stock Repurchase Program 50% to $1.5 Billion, Announces Q2 2025 Dividend of $0.25 per share

Comments

SS&C Technologies Hldgs

Noticias

Últimas noticias sobre SS&C Technologies Hldgs (NASDAQ:SSNC) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL